Back to Search
JYOTI SAXENA, M.D.
M.D.
Family Medicine Physician
NPI: 1407879273IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
A87189(CA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 1991
Research & Publications (20)
Lipid Lowering Activity of Anthocephalus indicus Root in Hyperlipidemic Rats.
PMID 18955320·Evid Based Complement Alternat Med·2010
8-other
Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity.
PMID 19665899·Bioorg Med Chem·2009
7-preclinical
Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials.
PMID 19339178·Bioorg Med Chem Lett·2009
7-preclinical
Dietary phytochemicals as rumen modifiers: a review of the effects on microbial populations.
PMID 19582589·Antonie Van Leeuwenhoek·2009
6-review
Antidyslipidemic and antioxidative activities of 8-hydroxyquinoline derived novel keto-enamine Schiffs bases.
PMID 18819730·Eur J Med Chem·2009
7-preclinical
Novel keto-enamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2H-benzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents.
PMID 18063225·Eur J Med Chem·2008
7-preclinical
Molecular cloning and characterization of Brugia malayi hexokinase.
PMID 18499511·Parasitol Int·2008
7-preclinical
Molecular cloning and characterization of Plasmodium falciparum transketolase.
PMID 18456347·Mol Biochem Parasitol·2008
7-preclinical
Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.
PMID 18064491·Parasitol Res·2008
7-preclinical
Synthesis of 4-amino-5-cyano-2, 6-disubstituted pyrimidines as a potential antifilarial DNA topoisomerase II inhibitors.
PMID 18991743·Med Chem·2008
7-preclinical
Expeditious and convenient synthesis of pregnanes and its glycosides as potential anti-dyslipidemic and anti-oxidant agents.
PMID 17485213·Bioorg Med Chem·2007
7-preclinical
DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes.
PMID 18001110·Inorg Chem·2007
8-other
Ability to control persistent asthma in obese versus non-obese children enrolled in an asthma-specific disease management program (breathmobile).
PMID 17092846·J Asthma·2006
4-observational
Search for new prototypes for the chemotherapy of filariasis: a chemotherapeutic and biochemical approach.
PMID 15739072·Parasitol Res·2005
7-preclinical
Synthesis and DNA topoisomerase-II inhibitory activity of unnatural nucleosides.
PMID 15715196·Nucleosides Nucleotides Nucleic Acids·2005
4-observational
Syntheses of 2,4,6-trisubstituted pyrimidine derivatives as a new class of antifilarial topoisomerase II inhibitors.
PMID 15582408·Bioorg Med Chem Lett·2005
7-preclinical
4-Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi.
PMID 14652743·Parasitol Res·2004
7-preclinical
Inflammatory antigens of Brugia malayi and their effect on rodent host Mastomys coucha.
PMID 15752117·Parasite Immunol·2004
7-preclinical
Synthesis and antifilarial evaluation of 7-O-acetamidyl-4-alkyl-2H-1-benzopyran-2-ones.
PMID 14732967·Arzneimittelforschung·2003
7-preclinical
Relationship of mould count, ergosterol and ochratoxin A production.
PMID 11764889·Int J Food Microbiol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2330 W COVELL BLVD
DAVIS, CA 95616 - Phone
- (530) 406-2854
Quick Facts
- NPI
- 1407879273
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile